PharmiWeb.com - Global Pharma News & Resources
02-Jul-2019

Point of Care Testing Market to Reach Approximately USD 38.40 Billion by 2026

The Global Point of Care Testing Market size is expected to reach USD 38.40 Billion by 2026 and growing CAGR around 7.4 % during the forecast period 2018 to 2026.

The Global Point of Care Testing Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report athttps://www.acumenresearchandconsulting.com/request-sample/1136

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Point of Care Testing Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Point of Care Testing Market?
  • What is the market drivers, restrains, opportunities governing the global Point of Care Testing Market?
  • Which is the largest and the fastest growing segments in the global Point of Care Testing Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Point of Care Testing Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues.

Few of the significant contributor in the global point of care industry are Abaxis, Abbott, Siemens AG, F. Hoffmann-La Roche Ltd., and Johnson and Johnson.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1136

The Major Market Segments of GlobalPoint of Care Testing Marketare as below:

Market Segmentation

Market By Product

  • Glucose monitoring
    • Strips
    • Meters
    • Lancets
  • Cardiometabolic testing products
    • Cardiac marker testing products
    • Blood Gas/Electrolytes testing products
    • HBA1C testing products
  • Infectious disease testing products
    • Influenza testing products
    • HIV testing products
    • Hepatitis C testing products
    • Sexually Transmitted Disease (STD) testing products
    • Healthcare-Associated Infection (HAI) testing products
    • Respiratory infection testing products
    • Tropical disease testing products
    • Other infectious diseases testing products
  • Coagulation testing products
    • PT/INR testing products
    • Activated Clotting Time (ACT/APTT) testing products
  • Pregnancy and fertility testing products
    • Pregnancy testing products
    • Fertility testing products
  • Tumor/Cancer marker testing products
  • Urinalysis testing products
  • Cholesterol testing products
  • Hematology testing products
  • Drug-of-Abuse (DoA) testing products
  • Fecal occult testing products
  • Other products

Market By Technology

  • Lateral flow assays
  • Dipsticks
  • Microfluidics
  • Molecular diagnostics
  • Immunoassays
  • Agglutination assays
  • Flow-Through
  • Solid phase
  • Biosensors

Market By Prescription

  • OTC testing
  • Prescription-based testing

Market By Application

  • Cardio metabolic testing
  • Infectious disease testing
  • Nephrology testing
  • Drug-of-Abuse (DoA) testing
  • Blood glucose testing
  • Pregnancy testing
  • Cancer biomarker testing
  • Other applications

Market By End-user

  • Hospitals
  • Diagnostic centers
  • Research laboratories
  • Home-care settings
  • Other end-uses

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Point of Care Testing
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Point of Care Testing Market By Product
1.2.2.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Point of Care Testing Market Revenue Share By Product in 2017
1.2.2.3. Glucose monitoring
1.2.2.4. Cardiometabolic testing products
1.2.2.5. Infectious disease testing products
1.2.2.6. Coagulation testing products
1.2.2.7. Pregnancy and fertility testing products
1.2.2.8. Tumor/Cancer marker testing products
1.2.2.9. Urinalysis testing products
1.2.2.10. Cholesterol testing products
1.2.2.11. Hematology testing products
1.2.2.12. Drug-of-Abuse (DoA) testing products
1.2.2.13. Fecal occult testing products
1.2.2.14. Others
1.2.3. Point of Care Testing Market By Technology
1.2.3.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.3.2. Global Point of Care Testing Market Revenue Share By Technology in 2017
1.2.3.3. Lateral flow assays
1.2.3.4. Dipsticks
1.2.3.5. Microfluidics
1.2.3.6. Molecular diagnostics
1.2.3.7. Immunoassays
1.2.3.8. Agglutination assays
1.2.3.9. Flow-Through
1.2.3.10. Solid phase
1.2.3.11. Biosensors
1.2.3.12. Others
1.2.4. Point of Care Testing Market By Prescription
1.2.4.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By Prescription (2015-2026)
1.2.4.2. Global Point of Care Testing Market Revenue Share By Prescription in 2017
1.2.4.3. Otc Testing
1.2.4.4. Prescription-Based Testing
1.2.4.5. Others
1.2.5. Point of Care Testing Market By Application
1.2.5.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison BY APPLICATION (2015-2026)
1.2.5.2. Global Point of Care Testing Market Revenue Share BY APPLICATION in 2017
1.2.5.3. Cardio metabolic testing
1.2.5.4. Infectious disease testing
1.2.5.5. Nephrology testing
1.2.5.6. Drug-of-Abuse (DoA) testing
1.2.5.7. Blood glucose testing
1.2.5.8. Pregnancy testing
1.2.5.9. Cancer biomarker testing
1.2.5.10. Others
1.2.6. Point of Care Testing Market By End-user
1.2.6.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison By End-user (2015-2026)
1.2.6.2. Global Point of Care Testing Market Revenue Share By End-user in 2017
1.2.6.3. Hospitals
1.2.6.4. Diagnostic centers
1.2.6.5. Research laboratories
1.2.6.6. Home-care settings
1.2.6.7. Others
1.2.7. Point of Care Testing Market by Geography
1.2.7.1. Global Point of Care Testing Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.7.2. North America Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.3. Europe Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.4. Asia-Pacific Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.5. Latin America Point of Care Testing Market Revenue and Growth Rate (2015-2026)
1.2.7.6. Middle East and Africa (MEA) Point of Care Testing Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Cardio metabolic testing Production Date of Global Point of Care Testing Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Point of Care Testing Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Point of Care Testing Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Point of Care Testing Major Manufacturers in 2017

CHAPTER 4. Point of Care Testing MARKET BY PRODUCT

4.1. Global Point of Care Testing Revenue By Product
4.2. Glucose monitoring
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Cardiometabolic testing products
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Infectious disease testing products
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Coagulation testing products
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Pregnancy and fertility testing products
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Tumor/Cancer marker testing products
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Urinalysis testing products
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.9. Cholesterol testing products
4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.10. Hematology testing products
4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.11. Drug-of-Abuse (DoA) testing products
4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.12. Fecal occult testing products
4.12.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.12.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.13. Others
4.13.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.13.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Point of Care Testing MARKET By Technology

5.1. Global Point of Care Testing Revenue By Technology
5.2. Lateral flow assays
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Dipsticks
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Microfluidics
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Molecular diagnostics
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Immunoassays
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.7. Agglutination assays
5.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.8. Flow-Through
5.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.9. Solid phase
5.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.10. Biosensors
5.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.11. Others
5.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Point of Care Testing MARKET By Prescription

6.1. Global Point of Care Testing Revenue By Prescription
6.2. Otc Testing
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Prescription-Based Testing
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Point of Care Testing MARKET BY APPLICATION

7.1. Global Point of Care Testing Revenue BY APPLICATION
7.2. Cardio metabolic testing
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Infectious disease testing
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Nephrology testing
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Drug-of-Abuse (DoA) testing
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Blood glucose testing
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Pregnancy testing
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.8. Cancer biomarker testing
7.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.9. Others
7.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. Point of Care Testing MARKET By End-user

8.1. Global Point of Care Testing Revenue By End-user
8.2. Hospitals
8.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.3. Diagnostic centers
8.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.4. Research laboratories
8.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.5. Home-care settings
8.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
8.6. Others
8.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 9. NORTH AMERICA Point of Care Testing MARKET BY COUNTRY

9.1. North America Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. North America Point of Care Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. U.S.
9.3.1. U.S. Point of Care Testing Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4. Canada
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5. Mexico
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 10. EUROPE Point of Care Testing MARKET BY COUNTRY

10.1. Europe Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Europe Point of Care Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. UK
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4. Germany
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5. France
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6. Spain
10.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7. Rest of Europe
10.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 11. ASIA-PACIFIC Point of Care Testing MARKET BY COUNTRY

11.1. Asia-Pacific Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Asia-Pacific Point of Care Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. China
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4. Japan
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5. India
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.6. Australia
11.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.6.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.7. South Korea
11.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.7.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.8. Rest of Asia-Pacific
11.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.8.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 12. LATIN AMERICA Point of Care Testing MARKET BY COUNTRY

12.1. Latin America Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Latin America Point of Care Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. Brazil
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4. Argentina
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5. Rest of Latin America
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 13. MIDDLE EAST Point of Care Testing MARKET BY COUNTRY

13.1. Middle East Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Middle East Point of Care Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
13.3. Saudi Arabia
13.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.4. UAE
13.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.5. Rest of Middle East
13.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 14. AFRICA Point of Care Testing MARKET BY COUNTRY

14.1. Africa Point of Care Testing Market Revenue and Growth Rate, 2015 - 2026 ($Million)
14.2. Africa Point of Care Testing Market Revenue Share Comparison, 2015 amp; 2026 (%)
14.3. South Africa
14.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
14.3.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
14.4. Egypt
14.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
14.4.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
14.5. Rest of Africa
14.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
14.5.2. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)

CHAPTER 15. COMPANY PROFILE

15.1. Abaxis
15.1.1. Company Snapshot
15.1.2. Overview
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Key Developments
15.1.6. Strategies
15.2. Abbott
15.2.1. Company Snapshot
15.2.2. Overview
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Key Developments
15.2.6. Strategies
15.3. Siemens AG
15.3.1. Company Snapshot
15.3.2. Overview
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Key Developments
15.3.6. Strategies
15.4. F. Hoffmann-La Roche Ltd.
15.4.1. Company Snapshot
15.4.2. Overview
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Key Developments
15.4.6. Strategies
15.5. Johnson and Johnson
15.5.1. Company Snapshot
15.5.2. Overview
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Key Developments
15.5.6. Strategies
15.6. Others
15.6.1. Company Snapshot
15.6.2. Overview
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Key Developments
15.6.6. Strategies

CHAPTER 16. RESEARCH APPROACH

16.1. Research Methodology
16.1.1. Initial Data Search
16.1.2. Secondary Research
16.1.3. Primary Research
16.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1136

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 02-Jul-2019